0001209191-23-045640.txt : 20230814 0001209191-23-045640.hdr.sgml : 20230814 20230814163139 ACCESSION NUMBER: 0001209191-23-045640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221121 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Robitaille Sebastien CENTRAL INDEX KEY: 0001838818 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36697 FILM NUMBER: 231171064 MAIL ADDRESS: STREET 1: C/O DBV TECHNOLOGIES S.A. STREET 2: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DBV Technologies S.A. CENTRAL INDEX KEY: 0001613780 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 BUSINESS PHONE: 33(0)155427878 MAIL ADDRESS: STREET 1: 177-181 AVENUE PIERRE BROSSOLETTE CITY: MONTROUGE STATE: I0 ZIP: 92120 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2022-11-21 0 0001613780 DBV Technologies S.A. DBVT 0001838818 Robitaille Sebastien C/O DBV TECHOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 FRANCE 0 1 0 0 Chief Financial Officer 0 Ordinary Shares 2022-11-21 4 A 0 8000 0.00 A 36500 D Employee Stock Option (right to buy) 3.07 2022-11-21 4 A 0 65000 0.00 A 2032-11-21 Ordinary Shares 65000 65000 D The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share. Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0242 to EURO 1.00 as of November 21, 2022. 25% of the shares subject to the option vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Jason Minio, Attorney-in-Fact 2023-08-14